We are live on ! Find out more
RXDX

Prometheus Biosciences, Inc. Common Stock
RXDX

Delisted

RXDX was delisted on the 15th of June, 2023.

Back to rankings

2 hedge funds and large institutions have $1.98M invested in Prometheus Biosciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 216 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% less call options, than puts

Call options by funds: $13.6M | Put options by funds: $51.5M

99% less funds holding

Funds holding: 219 → 2 (-217)

100% less capital invested

Capital invested by funds: $4.35B → $1.98M (-$4.35B)

100% less funds holding in top 10

Funds holding in top 10: 13 → 0 (-13)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 216

Holders
2
Holders Change
-217
Holders Change %
-99.09%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-13
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
216
Calls
$13.6M
Puts
$51.5M
Net Calls
-$37.9M
Net Calls Change
-$118M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$351M
2
BlackRock
BlackRock
New York
-$300M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$292M
4
BC
Boxer Capital
California
-$204M
5
7IH
72 Investment Holdings
Connecticut
-$198M
Name Holding Trade Value Shares
Change 		Change in
Stake
SHIM
201
Stone House Investment Management
Pennsylvania
– -$10.7K -100 Closed
QCG
202
Quadrant Capital Group
Ohio
– -$7.83K -73 Closed
C
203
Covestor
United Kingdom
– -$8K -72 Closed
AF
204
Allworth Financial
California
– -$7.08K -66 Closed
EI
205
Ellevest Inc
New York
– -$6.33K -59 Closed
Walleye Trading
206
Walleye Trading
New York
– -$6.22K -58 Closed
OLVIG
207
Oliver Lagore Vanvalin Investment Group
Michigan
– -$5.04K -47 Closed
PTC
208
Private Trust Company
Ohio
– -$3.97K -37 Closed
CG
209
Cutler Group
California
– -$3K -30 Closed
BIA
210
Bell Investment Advisors
California
– -$1.5K -14 Closed
LC
211
Lindbrook Capital
California
– -$1.29K -12 Closed
EWA
212
EverSource Wealth Advisors
Alabama
– -$1.07K -10 Closed
ASN
213
Advisory Services Network
Georgia
– -$859 -8 Closed
BWL
214
Bogart Wealth LLC
Virginia
– -$751 -7 Closed
FFA
215
Farther Finance Advisors
California
– -$644 -6 Closed
GRP
216
Global Retirement Partners
California
– -$971 -5 Closed
S
217
SignatureFD
Georgia
– -$107 -1 Closed
TWD
218
True Wealth Design
Ohio
– -$108 -1 Closed
5 6 7 8
9

RXDX Hedge Fund Activity: Q2 2023 in Review

2 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Prometheus Biosciences, Inc. Common Stock (RXDX) for Q2 2023, worth a combined $1.98M — down 100% from $4.35B a quarter earlier.

Sellers outnumbered buyers: 216 funds closed out of RXDX and 0 opened new positions — a net loss of 216 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RTW Investments, exiting entirely with an estimated $351M sold.

  • 2 institutional investors held Prometheus Biosciences, Inc. Common Stock (RXDX) as of Q2 2023, down from 219 in Q1 2023.
  • Funds reported $1.98M of Prometheus Biosciences, Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Prometheus Biosciences, Inc. Common Stock positions in Q2 2023 and 216 closed out, a net change of -216 holders.
  • The largest Prometheus Biosciences, Inc. Common Stock seller in Q2 2023 was RTW Investments, an estimated $351M sold.

Based on aggregated 13F filings for Q2 2023.